Psoriasis I-4
Crohn's disease I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW & OUTLOOK II-1
Autoimmune Disease Therapeutics Market Continues to Flourish II-1
Pharmaceutical Industry Hit by Economic Downturn II-1
Credit Crunch to Affect Biological Drug Pipeline II-1
Biotech Bankruptcies Rife in the Current Economic Downturn II-2
Economic Downturn Takes Toll on R&D II-2
Global Market Estimates and Forecasts II-2
Analysis by Region II-2
Analysis by Segment II-3
2. MARKET DYNAMICS AND TRENDS II-4
Biologics Continue to Gain Market Share II-4
New Products to Drive Market Growth II-4
Biogenerics to Expand Adoption of Biological Drugs II-4
New Indications to Fuel Market Growth II-5
Superior Outcomes to Enhance Adoption of Biologics II-5
Efficacy and Convenience - Key Factors Driving Physician's
Decision II-5
3. DISEASE OVERVIEW II-6
Immunity and Immune System II-6
Autoimmune Diseases II-6
Women- Highly Susceptible to Autoimmune Diseases II-6
Table 1: Percentage Breakdown of Incidence of Autoimmune
Diseases in Men and Women (includes corresponding
Graph/Chart) II-7
Complexity in Manifestations Renders Difficulty in
Understanding the Conditions II-7
Etiology of Autoimmune Diseases II-8
Genetic Predisposition II-8
Environmental Factors II-9
Autoimmune Diseases - A Social and Health Burden II-9
Regulatory Glitches and High Costs Hinder Biogenerics II-9
Types of Autoimmune Diseases II-10
Incidence and Prevalence II-11
Diagnosis and Treatment of Autoimmune Diseases II-11
Overview on Select Biologic Drugs II-11
Remicade II-11
Humira II-12
Rituxan(R) (rituximab) II-12
Cimzia II-13
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |